Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Parentheticals)

v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Parentheticals) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Mar. 31, 2021
Increase (Decrease) in Stockholders' Equity                    
Total stockholders' deficit $ (121,498) $ (101,931) $ (94,433) $ (91,321) $ (84,369) $ (77,963) $ (82,535) $ (76,500) $ (143,739) $ (199,936) [1]
Accumulated Deficit                    
Increase (Decrease) in Stockholders' Equity                    
Total stockholders' deficit (827,380) (808,436) (798,567) (795,236) (786,094) (775,914) (776,027) (768,604) (767,726) (806,081) [1]
Additional Paid-in Capital                    
Increase (Decrease) in Stockholders' Equity                    
Total stockholders' deficit $ 707,116 $ 706,133 $ 705,230 704,309 702,370 699,536 696,567 693,896 624,805 606,431 [1]
Adjustments                    
Increase (Decrease) in Stockholders' Equity                    
Total stockholders' deficit       $ 2,759 2,519 $ (910) $ (3,193) $ (7,713) (17,056) (87,691)
Adjustments | Accumulated Deficit                    
Increase (Decrease) in Stockholders' Equity                    
Total stockholders' deficit         22,752       3,177 (67,458)
Adjustments | Additional Paid-in Capital                    
Increase (Decrease) in Stockholders' Equity                    
Total stockholders' deficit         $ (20,233)       $ (20,233) $ (20,233)
[1] The March 31, 2021 ending total shareholders’ deficit reflects the impact of the restatement totaling $87.7 million related to SSP and warrant classification adjustments prior to that time, including a $67.5 million increase of Accumulated deficit and a $20.2 million decrease of Additional paid-in -capital.